✦ LIBER ✦

Superiority of high-dose over intermediate-dose cytosine arabinoside in the treatment of patients with high-risk acute myeloid leukemia: results of an age-adjusted prospective randomized comparison

✍ Scribed by Kern, W; Aul, C; Maschmeyer, G; Schönrock-Nabulsi, R; Ludwig, W D; Bartholomäus, A; Bettelheim, P; Wörmann, B; Büchner, T; Hiddemann, W

Book ID: 110053889
Publisher: Nature Publishing Group
Year: 1998
Tongue: English
Weight: 75 KB
Volume: 12
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2401066

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose cytosine arabinoside in the tr

High-dose cytosine arabinoside in the treatment of acute myeloid leukemia : Review of three randomized trials

✍ Wolfgang Kern; Elihu H. Estey 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 400 KB 👁 1 views

Treatment of acute nonlymphocytic leukem

Treatment of acute nonlymphocytic leukemia in the elderly with intermediate high-dose cytosine arabinoside

✍ Letendre, Louis ;Niedringhaus, Robert D. ;Therneau, Terry M. ;Gastineau, Dennis 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB 👁 1 views

Effective treatment of the elderly patients (265 years) with acute nonlymphocytic leukemia (ANLL) remains elusive and controversial. In the present study, single-agent Cytosine Arabinoside (AM-C) was administered at an intermediate dose level (500 mg/m2 intravenously [I.V.] I-hour infusion q12 hours

High-dose VP-16 with intermediate-dose c

High-dose VP-16 with intermediate-dose cytosine arabinoside in the treatment of relapsed acute nonlymphocytic leukemia

✍ Hon Y. Chan; Frederick J. Meyers; Jerry P. Lewis 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 147 KB

Limited efficacy of a four-day course of

Limited efficacy of a four-day course of high-dose cytosine arabinoside in the treatment of poor-risk patients with acute nonlymphocytic leukemia

✍ Harvey D. Preisler; Azra Raza; Richard Larson; George Browman; Jack Goldberg; Ha 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 351 KB

Comparison of toxicity and outcome in pa

Comparison of toxicity and outcome in patients with acute myeloid leukemia treated with high-dose cytosine arabinoside consolidation after induction with a regimen containing idarubicin or daunorubicin

✍ G. Seipelt; W.-K. Hofmann; H. Martin; B. Wassmann; A. Boehme; O. G. Ottmann; D. 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 205 KB

A comparison of low-dose cytarabine and

A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment

✍ Alan K. Burnett; Donald Milligan; Archie G. Prentice; Anthony H. Goldstone; Mary 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views